Abate As Industries share price
BSE: 531658Healthcare ServicesSmall Cap
ABATE AS INDUSTRIES LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1996
Last close ₹7.19up ₹0.12 (1.70%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹7.07.
28 Oct: open ₹7.30, high ₹7.30, low ₹6.55
52-week range of traded prices to 28 Oct 2026
₹6.16Low, 21 Oct 2026₹20.11High, 13 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹113 Cr2,442nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 9.22
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.65
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.05
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,713
Results
Standalone, as consolidated accounts are on record for only 2 of the last ten years; ₹ crore.Abate As Industries quarterly results
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. Under it, revenue in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- ₹0.00 CrQuarter to Mar 2026: ₹0.00 Cr
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹0.14 Crdown 42.06%
Revenue by quarter
Peak revenue ₹0.00 Cr, quarter to Sep 2024
Net profit by quarter, a loss in red
- Net profit
- Loss
A loss in 2 of the 8 quarters shown
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net profit | −0.03 | −0.02 | 0.63 | 0.13 | 0.84 | 0.28 | 0.25 | 0.14 |
Standalone. The last eight quarters. The latest is shaded.
Year to Mar 2026, against the year before
- RevenueRevenue. Under it, revenue in the year before. A change in per cent is not worked out where either period is a loss or nothing.
- ₹0.00 CrYear to Mar 2025: ₹0.00 Cr
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹1.55 Crup 184.80%
Revenue by year
Peak revenue ₹0.08 Cr, year to Mar 2017; lowest ₹0.00 Cr, year to Mar 2020
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 5 of the 10 years shown
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.08 | 0.05 | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net profit | −0.01 | −0.03 | 0.00 | 0.02 | 0.01 | −0.34 | −0.35 | −0.91 | 0.54 | 1.55 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary | −18.7% | −65.4% | – | – | – | – | – | – | – | – |
Standalone. Years to March. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, Healthcare, which carries all its revenue.
Valuation
Today, against the company's own history. Dividend yield is not shown: no dividend in the years on record.Abate As Industries PE ratio and valuation
Price to earnings
At or below today's level on 2% of 247 trading days over the last year.
LowestHighest
Its median15.80Industry median43.15
Price to book
At or below today's level on 2% of 247 trading days over the last year.
LowestHighest
Its median0.99Industry median4.88
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +15.4% | +184.8% | −59.5% | 0.0% |
| 3 years | +9.7% | – | – | 0.0% |
| 5 years | +49.2% | +63.7% | −8.9% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1 year is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Promoter and insider buying and selling
Trades made since 29 Oct 2025.Abate As Industries insider trading
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group2 purchases, 0 sales₹0.62 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹0.62 Cr1 off-market move
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Abate As Industries competitors and peers
Hospital, 40 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Abate As Industries in market cap. 3 companies in the table last traded before then: their rows are priced on their last trade.Healthcare companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Aashka HospitalsAASHKA | 229 | 68.65 | 2.22 | +1.6% | +2.2% | 3.3% | – | 0.00% |
 Lotus Eye Hospital and InstituteLOTUSEYE | 228 | 1,525.81 | 3.79 | +14.1% | −77.4% | 0.2% | 0.4% | 0.00% |
 Hannah Joseph HospitalHANNAH | 225 | 20.14 | 2.31 | – | – | 11.5% | 14.9% | 2.02% |
 Nephro Care IndiaNEPHROCARE | 133 | – | – | – | – | – | – | 0.00% |
 Sangani HospitalsSANGANI | 86 | 28.82 | 2.11 | +404.9% | +15.5% | 7.8% | – | 0.00% |
 Maitreya MedicareMAITREYA | 85 | – | 3.05 | −2.5% | −2,152.0% | −11.3% | – | 0.00% |
 Fortis Malar HospitalsFORTISMLR | 76 | 555.81 | 2.21 | +49.3% | −97.0% | 0.4% | −4.6% | 0.00% |
 Shanmuga HospitalSHANMUGA | 56 | 13.27 | 1.31 | −0.9% | +0.1% | 10.2% | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Abate As Industries announcements
Oct 2026
Sep 2026
Aug 2026
22 Aug · Announcement Under Reg 36(1)(B) Of SEBI (LODR) Regulations,2015.
22 Aug · Corporate action
Abate As Industries share price by year
Each calendar year to 2025.Abate As Industries share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 17.50 | +100.5% | 25.87 | 8.73 |
| 2024 | 8.73 | −22.4% | 15.07 | 7.76 |
| 2023 | 11.25 | +54.6% | 11.25 | 7.28 |
| 2022 | 7.28 | +43.2% | 7.28 | 3.89 |
| 2021 | 5.08 | +272.2% | 5.96 | 1.30 |
| 2020 | 1.37 | +0.4% | 1.37 | 1.00 |
| 2019 | 1.36 | +8.8% | 1.50 | 1.19 |
| 2018 | 1.25 | +47.9% | 1.25 | 0.88 |
| 2017 | 0.85 | +3.0% | 1.07 | 0.60 |
| 2016 | 0.82 | −14.6% | 1.30 | 0.72 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2019 is from its first session, 1 Mar 2019. The close is the year's last trade for 2019 (2 Dec 2019) and 2018 (9 Aug 2018).
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 27 Oct 2026 | 7.30 | 7.45 | 6.51 | 7.07 | 6.98 | 12,917 |
| 26 Oct 2026 | 6.80 | 7.30 | 6.50 | 7.29 | 7.00 | 40,382 |
| 23 Oct 2026 | 6.93 | 7.00 | 6.57 | 6.80 | 6.82 | 40,996 |
| 22 Oct 2026 | 6.96 | 6.96 | 6.40 | 6.87 | 6.68 | 18,936 |
| 21 Oct 2026 | 7.10 | 7.64 | 6.16 | 6.65 | 6.58 | 56,568 |
| 19 Oct 2026 | 7.76 | 7.76 | 6.26 | 7.30 | 6.91 | 31,347 |
| 16 Oct 2026 | 7.90 | 7.99 | 7.40 | 7.60 | 7.70 | 36,914 |
| 15 Oct 2026 | 7.60 | 8.95 | 7.27 | 7.90 | 7.82 | 40,491 |
| 14 Oct 2026 | 7.65 | 7.65 | 7.20 | 7.50 | 7.45 | 28,721 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Bonus share history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 31 Jul 2025 | Bonus | 0.5000 | Holders received 1 bonus share for every 1 held. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- BSE code
- 531658
- ISIN
- INE454E01013
- Industry
- Healthcare Services
- Website
- www.abateas.com
- CIN
- L65990TZ1991PLC029162
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1991
- Registered office
- SF NO 348/1, Ettimadai Village, Kg Chavady (Atm), Coimbatore 641105, Tamil Nadu
- Share registrar
- Purva Sharegistry (India) Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments